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Background/Aims: Neurologically impaired patients fre-
quently suffer from gastrointestinal tract problems, such 
as gastroesophageal reflux disease (GERD). In this study, 
we aimed to define the risk factors for GERD in neurologi-
cally impaired children. Methods: From May 2006 to March 
2014, 101 neurologically impaired children who received 
24-hour esophageal pH monitoring at Severance Children’s 
Hospital were enrolled in the study. The esophageal pH 
finding and the clinical characteristics of the patients were 
analyzed. Results: The reflux index was higher in patients 
with abnormal electroencephalography (EEG) results than 
in those with normal EEG results (p=0.027). Mitochondrial 
disease was associated with a higher reflux index than were 
epileptic disorders or cerebral palsy (p=0.009). Patient gen-
der, feeding method, scoliosis, tracheostomy, and baclofen 
use did not lead to statistical differences in reflux index. Age 
of onset of neurological impairment was inversely correlated 
with DeMeester score and reflux index. Age at the time of 
examination, the duration of the disease, and the number 
of antiepileptic drugs were not correlated with GER severity. 
Conclusions: Early-onset neurological impairment, abnormal 
EEG results, and mitochondrial disease are risk factors for 
severe GERD. (Gut Liver 2017;11:232-236)
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INTRODUCTION
As the central nervous system controls the enteric nervous 
system, neurologically impaired patients (NIP) frequently suf-
fer from gastrointestinal tract dysfunction.1 Del Giudice et al.2 
reported that 92% of children with cerebral palsy had clinically 
significant gastrointestinal symptoms: gastroesophageal reflux, 
77%; swallowing difficulties, 60%; chronic pulmonary aspira-
tion, 41%; and chronic constipation, 74%. Decreased lower 
esophageal sphincter tone, delayed gastric emptying, impaired 
esophageal motility, poor posture, recurrent seizures, scoliosis, 
and various medications are thought to contribute to gastro-
esophageal reflux disease (GERD) in neurologically impaired 
children.3 Respiratory symptoms, which are frequent in NIP, are 
also thought to aggravate GERD.4 Despite its high incidence, 
GERD in neurologically impaired children is difficult to recog-
nize as the symptoms of GER are nonspecific and many patients 
cannot precisely express their symptoms. Therefore, diagnosis 
of GERD in NIP is often delayed until severe esophagitis or 
fatal aspiration pneumonia occurs.5 As GER is closely related 
with aspiration pneumonia or food refusal, this can be a large 
obstacle to appropriate nutritional support of NIP, which can 
result in a poor clinical prognosis. This is why physicians should 
pay attention to GER in NIP. Early suspicion and evaluation can 
prevent severe complications of GERD in NIP and can lead to 
better clinical outcomes. In this study, we analyze the degree of 
gastroesophageal reflux according to patient characteristics and 
define the risk factors for GERD in neurologically impaired chil-
dren.
MATERIALS AND METHODS
1. Study population and data collection
Data from pediatric patients who received 24-hour esopha-
geal pH monitoring in Severance Children’s Hospital from May 
2006 to March 2014 were collected. Of those cases, neurologi-
cally impaired children were selected for the study. The reasons 
for performing 24-hour esophageal pH monitoring varied, but 
most patients had symptoms of gastroesophageal reflux such as 
recurrent aspiration pneumonia, grunting after meals, frequent 
regurgitation, and unexplained food refusal or food-related 
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irritability, or tonic posture. Patients who received upper gas-
trointestinal operations such as Nissen fundoplication or whose 
medical records were incomplete were excluded from this study. 
Finally, 101 patients (median age, 23.4 months) were enrolled. 
The results of esophageal pH monitoring and the clinical char-
acteristics of the patients were analyzed. Patient selection and 
data collection were performed by retrospectively reviewing 
medical records. 
2. 24-Hour esophageal pH monitoring
To allow for an accurate diagnosis, histamine 2 receptor an-
tagonist and proton pump inhibitor medications were discontin-
ued at least 3 days and 7 days before examination, respectively. 
Prokinetic drugs were also discontinued for more than 3 days. A 
pH-monitoring catheter probe was inserted through the nose to 
the distal esophagus. The tip of the pH electrode was placed on 
the third vertebral body above the diaphragm, as confirmed by 
fluoroscopy. Reflux index (%), the percentage of the time dur-
ing the investigation in which pH <4, was used for analysis. For 
infants and children, more than 12% and 6% was considered 
pathologic reflux respectively. DeMeester score, which reflects 
the number of acid refluxes, number of long acid refluxes, dura-
tion of the longest acid reflux, and fraction of time that the pH 
was below 4.00, were also used for the comparison. 
3. Statistical analysis
Reflux index was compared between groups according to 
diagnosis, feeding type (oral feeding, nasogastric tube feeding, 
or gastrostomy feeding), scoliosis status, ventriculoperitoneal 
shunt status, tracheostomy status, electroencephalography (EEG) 
results, brain magnetic resonance imaging (MRI) results and 
baclofen use. Correlations of reflux index and DeMeester score 
to disease onset age, age at examination, duration of disease, 
and number of antiepileptic drugs (AED) were analyzed as well. 
The Mann-Whitney test, Kruskal-Wallis test, and Spearman cor-
relation test were used for the analysis. All statistical analyses 
were performed using SPSS software version 18.0 (SPSS Inc., 
Chicago, IL, USA). A p-value <0.05 was considered statistically 
significant.
RESULTS
Patients were divided according to their clinical characteris-
tics. Distributions and descriptive statistics are given in Table 1. 
All patients were under the age of 18. Causes of neurologic im-
pairment were heterogeneous and included perinatal asphyxia, 
genetic abnormality, cerebral hemorrhage or infarction, hypoxic 
brain damage, brain tumor, and infections of the central ner-
vous system. Substantial numbers of patients had developed 
neurologic impairment without a definite cause. The main di-
agnoses of the patients were variable as well, such as Lennox-
Gastaut syndrome, infantile spasm, cerebral palsy, mitochon-
drial disease, Dravet syndrome, and so on. When we compared 
reflux index according to disease category, the mitochondrial 
disease group (n=19) had a higher reflex index than did the 
other epilepsy group (n=67) or the cerebral palsy group (n=8) 
(p=0.009). The median reflux index values were 14.4, 3.9, and 
3.5, respectively (Fig. 1). Patient gender, feeding method, sco-
Table 1. Patient Characteristics
Variable Value
Categorical variable
    Sex
        Male 59 (58.4)
        Female 42 (41.6)
    EEG
        Normal 9 (8.9)
        Abnormal 92 (91.1)
    Baclofen
        With baclofen 19 (18.8)
        Without baclofen 82 (81.2)
    Tracheostomy
        With tracheostomy 9 (8.9)
        Without tracheostomy 92 (91.1)
    V-P shunt
        With V-P shunt 5 (5.0)
        Without V-P shunt 96 (95.0)
    Scoliosis
        With scoliosis 36 (35.5)
        Without scoliosis 65 (64.4)
    Feeding route
        Oral 45 (44.6)
        Nasogastric tube 48 (47.5)
        Gastrostomy 8 (7.9)
    Main diagnosis
        Epilepsy 67 (66.3)
        Mitochondrial disease 19 (18.8)
        Cerebral palsy 8 (7.9)
        Others 7 (6.9)
    Brain MRI
        Normal  25 (24.7)
        Abnormal  76 (75.2)
    Total 101 (100)
Continuous variable
    Age, mo  23.4 (10.5–44.1)
    Disease onset age, mo 3 (0–6)
    Duration of disease, mo  15.4 (7.35–30.75)
    No. of AED 3 (2–4)
Data are presented as number (%) or median (interquartile range).
EEG, electroencephalography; V-P shunt, ventriculoperitoneal shunt; 
MRI, magnetic resonance imaging; AED, antiepileptic drug.
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liosis, tracheostomy, brain MRI results and baclofen use did not 
lead to statistically significant differences in reflux index. Re-
flux index was significantly higher in the abnormal EEG group 
than in the normal EEG group (p=0.027) (Fig. 1).
The age at examination, duration of the disease, and number 
of AED did not correlate with reflux index or DeMeester score. 
However, age of onset of neurological impairment was inversely 
correlated with DeMeester score (correlation coefficient, –0.389; 
p<0.001). Reflux index (%) and disease onset age also dem-
onstrated a similar tendency (correlation coefficient, –0.371; 
p<0.001), which means that early onset of neurologic impair-
ment can aggravate GER (Table 2). 
DISCUSSION
GER refers to retrograde passage of gastric contents to the 
esophagus, pharynx, or oral cavity. GERs can be normal physi-
ological events which occur frequently even in healthy individ-
uals.6 However, severe GER can cause troublesome symptoms or 
complications and can impair health-related quality of life.7 This 
condition is called GERD. GERD is much more prevalent in NIP 
than in the normal population, and it can be a significant ob-
stacle to ensuring adequate nutrition. In clinical practice, neuro-
logically impaired children are often malnourished and malnu-
trition and GER can negatively impact one another.8,9 Therefore, 
both conditions should be monitored and managed attentively. 
Furthermore, due to a lack of effective communication, GERD is 
often diagnosed belatedly. GER is also closely related to respira-
tory problems. Recurrent pulmonary infections can be caused 
that give rise to poor prognoses.10 Thus, GERD can decrease a 
patient’s quality of life both directly and indirectly. If GER can 
be predicted in NIP, appropriate evaluation and management 
measures can be taken, which will lead to better long-term 
outcomes. To our knowledge, this is the first study to define the 
clinical risk factors of GER in neurologically impaired children. 
Although GER is a relatively common problem in both 
normal infants and NIP, the mechanisms of GER are not com-
pletely understood. Transient relaxation of the lower esophageal 
sphincter (LES) has been reported to be a main mechanism of 
GER in children.11,12 On the other hand, in NIP, absence of LES 
tone is thought to be the main mechanism rather than transient 
relaxation of the LES.13 Delayed gastric emptying and decreased 
antroduodenal motor function have also been suggested as 
mechanisms of GER in NIP.14,15 As the mechanisms of GER 
in NIP are complicated and poorly understood, it is difficult 
to predict and prevent GERD in such patients. This study was 
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Fig. 1. Box and whisker plot of reflux 
index showing the reflux index distri-
bution according to clinical condition. 
The box represents the interquartile 
range, and the line in the box indicates 
the median value. Differences with a p-
value of <0.05 are marked. 
MRI, magnetic resonance imaging; MD, 
mitochondrial disease; NG, nasogastric; 
V-P, ventriculoperitoneal shunt; EEG, 
electroencephalography.
Table 2. Spearman Correlation Coefficients of the Gastroesophageal Reflux Index and DeMeester Score with Continuous Variables
DeMeester score Reflux index
Correlation coefficient p-value Correlation coefficient p-value
Disease onset Age -0.389 <0.001 -0.371 <0.001
Examination Age -0.31 0.760 -0.050 0.621
Duration of disease 0.180 0.071 0.159 0.113
No. of AED 0.083 0.409 0.122 0.224
AED, antiepileptic drug.
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designed to identify the risk factors for GER in neurologically 
impaired children. 
In this study, early-onset neurological impairment was related 
to more severe GER. This finding may be because early-onset 
neurological diseases tend to be related to congenital neuro-
logic anomalies or genetic mutations which bring about major 
neurologic sequelae, and, accordingly, severe systemic compli-
cations. In a previous study, 67% of otherwise healthy infants 
were found to have GER at 4 months of age.16 This is due to 
frequent feeding, short esophagi, the wide angle between the 
esophagus and stomach, and the amount of time infants spend 
in the supine position rather than in an upright position.17 This 
physiologic GER was alleviated in the course of normal growth, 
development, and transition to solid food. Only 5% of otherwise 
healthy children have GER at 12 months of age.16 In early-onset 
NIP, such normal developmental progress can be halted and 
GER may persist throughout life. Therefore, additional attention 
to GERD and aspiration is necessary for patients with infantile-
onset neurologic impairment. Although we also hypothesized 
that a long duration of morbidity might affect the severity of 
GER, the two were not significantly associated. Disease duration 
does not seem to be a significant factor for progression of GER 
in NIP.
The clinical manifestations of neurological diseases are dif-
ferent according to the diagnosis. Therefore, we compared the 
severity of GER amongst patients with different categories of 
disease. As the causes and diagnoses of neurologic impairment 
were heterogeneous, we categorized them as mitochondrial 
disease, epileptic disorders other than mitochondrial disease, 
cerebral palsy, and others. Patients with mitochondrial disease 
showed a higher reflux index than did those with other diseases. 
Mitochondrial disease is a multisystemic disorder that is fre-
quently associated with gastrointestinal and hepatic manifesta-
tions.18 Bhardwaj et al.19 demonstrated that children with mito-
chondrial disease had frequent gastrointestinal symptoms, such 
as abdominal pain, GER, and constipation, which are thought 
to be related to impaired gastric emptying and small bowel 
transit time, and which respond poorly to medications. This 
result suggests that young NIP with mitochondrial disease are 
at additional risk for GER. Not only neurologic impairment but 
also mitochondrial disease itself may contribute to this result. 
However, additional randomized controlled studies are required 
to fully elucidate this matter. 
In a previous study, somewhat different characteristics were 
seen between nasogastric tube fed and orally fed children, and 
orally fed NIP were at an increased risk for aspiration.1 Feeding 
route and physical characteristics of food may influence upper 
gastrointestinal motility and gastric emptying. However, in the 
present study, statistical differences were not observed between 
the gastrostomy, nasogastric tube, and orally fed groups. As 
patients in the three groups tended to have different clinical 
conditions, confounding factors may have affected the results.
To compare objective conditions, the patients with ventricu-
loperitoneal shunts or tracheostomy or scoliosis were analyzed 
with the patients who did not have the conditions. As a result, 
such conditions did not statistically affect reflux activity. In the 
case of EEG, the normal EEG group had a lower reflux index 
than did the abnormal EEG group. This means that abnormal 
EEG can be considered a risk factor for GERD in NIP. However, 
this does not mean that seizure activity aggravates GERD direct-
ly, as the number of AED, which is an indicator of intractable 
seizures, is not correlated with reflux activity. Rather, abnormal 
brain function itself most likely affected reflux activity.
As many patients with neurological problems suffer from 
tonic posture, baclofen is sometimes used as a muscle relaxant. 
Because it is a GABA type B receptor agonist, baclofen is known 
to decrease postprandial acid reflux by reducing transient LES 
relaxation.20,21 Kawai et al.22 reported that administration of 
baclofen reduced the frequency of vomiting and acid reflux in 
neurologically impaired children. Although we attempted to 
investigate the antireflux effect of baclofen in this study, no sig-
nificant differences existed between the baclofen-treated group 
(1 mg/kg/day) and the group not taking baclofen. This result 
may be negatively affected by spasticity itself, the reason for 
baclofen treatment. 
This study has several limitations. First, the study popula-
tion was heterogeneous. Patients with several different types 
of neurological impairments were included, and their clinical 
conditions were variable. Second, the reasons for performing 
24-hour esophageal pH monitoring were diverse. Some patients 
had severe recurrent aspiration pneumonia, whereas others 
had mild irritability. The decision to perform the test depended 
on individual physicians, which may have introduced a selec-
tion bias. Although we have discontinued medications such as 
proton pump inhibitor or H2 blocker to exclude the medication 
effect, we could not completely control other medications (e.g., 
baclofen or AED) which might potentially affect pH monitoring. 
Generally, it is believed that combined 24-hour multichannel 
intraluminal impedance-pH monitoring is much more accurate 
and reliable method than pH monitoring alone, especially in 
monitoring the NIP.1 As we could not evaluate intraluminal im-
pedance, this can be a main limitation of this study.
As several complex clinical factors may influence GER, it is 
difficult to predict the degree of GER just by using objective 
clinical factors in severely ill, neurologically impaired children. 
However, as the results of this study show, early onset neuro-
logic impairment, mitochondrial disease, and abnormal EEG 
can be important risk factors for severe GER. Accordingly, early 
suspicion and proper evaluations of GER are needed for those 
patients.
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